A Phase I Study of XJ101 in Chinese Healthy Subjects

Clinical trial NCT06014736 · UNKNOWN

Trial details

NCT number: NCT06014736
Sponsor: Starmab biologics（Shanghai）Co,.ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Staphylococcus Aureus Bloodstream Infection

Start date: 2023-08-15
Primary completion: 2024-03-26
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.